share_log

HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $10 Price Target

Benzinga ·  Mar 21, 2023 06:21

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment